Plasma IL-12 levels are suppressed in vivo by stress and surgery through endogenous release of glucocorticoids and prostaglandins but not catecholamines or opioids

Psychoneuroendocrinology

Volumn 42, Issue , 2014, Pages 11-23

  Shaashua, Lee ^a   Rosenne, Ella ^a   Neeman, Elad ^a   Sorski, Liat ^a   Sominsky, Luba ^a,b   Matzner, Pini ^a   Page, Gayle G ^c   Ben Eliyahu, Shamgar ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF NURSING   (United States)

Author keywords

Catecholamine; Epinephrine; Glucocorticoid; In vivo; Interleukin 12; Opioid; Prostaglandin; Stress; Surgery

Indexed keywords

ADRENALIN; CATECHOLAMINE; CORTICOSTERONE; CPG OLIGODEOXYNUCLEOTIDE; ENDORPHIN; GLUCOCORTICOID; INTERLEUKIN 12; PROSTAGLANDIN; PROSTAGLANDIN E2;

ADRENALECTOMY; ADRENALIN RELEASE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; IN VITRO STUDY; IN VIVO STUDY; LAPAROTOMY; MALE; NEUROENDOCRINOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SURGICAL STRESS;

CATECHOLAMINE; EPINEPHRINE; GLUCOCORTICOID; IN VIVO; INTERLEUKIN-12; OPIOID; PROSTAGLANDIN; STRESS; SURGERY;

ADRENALECTOMY; ANIMALS; CORTICOSTERONE; EPINEPHRINE; INTERLEUKIN-12; MALE; NALOXONE; NARCOTIC ANTAGONISTS; PROSTAGLANDINS; RATS; RATS, INBRED F344; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL;

EID: 84895871455     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2013.12.001     Document Type: Article

References (53)

1. Barnes P.J. Mechanisms of action of glucocorticoids in asthma. Am. J. Respir. Crit. Care Med. 1996, 154:S21-S26. discussion S26/S27.
2. Baxevanis C.N., Reclos G.J., Gritzapis A.D., Dedousis G.V., Missitzis I., Papamichail M. Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer. Cancer 1993, 72:491-501.
3. Ben-Eliyahu S., Rosenne E., Sorski L., Levi B. Second thoughts on the role of glucocorticoids in the in vino suppression of NK activity following stress. 17th Annual Meeting of the PsychoNeuroImmunology Research Society 2010, S23. Abstract # 292; vol. 24 (suppl 1). 10.1016/j.bbi.2010.07.075.
4. Ben-Eliyahu S., Shakhar G., Page G.G., Stefanski V., Shakhar K. Suppression of NK cell activity and of resistance to metastasis by stress: a role for adrenal catecholamines and beta-adrenoceptors. Neuroimmunomodulation 2000, 8:154-164.
5. Benish M., Bartal I., Goldfarb Y., Levi B., Avraham R., Raz A., Ben-Eliyahu S. Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Ann. Surg. Oncol. 2008, 15:2042-2052.
6. + lymphocytes. J. Immunol. 1997, 158:5589-5595.
7. Bornstein S.R., Ehrhart-Bornstein M. Ultrastructural evidence for a paracrine regulation of the rat adrenal cortex mediated by the local release of catecholamines from chromaffin cells. Endocrinology 1992, 131:3126-3128.
8. Bornstein S.R., Gonzalez-Hernandez J.A., Ehrhart-Bornstein M., Adler G., Scherbaum W.A. Intimate contact of chromaffin and cortical cells within the human adrenal gland forms the cellular basis for important intraadrenal interactions. J. Clin. Endocrinol. Metab. 1994, 78:225-232.
9. + lymphocytes by inhibiting IL-12 production. J. Immunol. 1998, 160:2231-2237.
10. DeTurck K.H., Vogel W.H. Factors influencing plasma catecholamine levels in rats during immobilization. Pharmacol. Biochem. Behav. 1980, 13:129-131.
11. Ehrhart-Bornstein M., Hinson J.P., Bornstein S.R., Scherbaum W.A., Vinson G.P. Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr. Rev. 1998, 19:101-143.
12. Elenkov I.J., Chrousos G.P., Wilder R.L. Neuroendocrine regulation of IL-12 and TNF-alpha/IL-10 balance. Clinical implications. Ann. N. Y. Acad. Sci. 2000, 917:94-105.
13. Elenkov I.J., Papanicolaou D.A., Wilder R.L., Chrousos G.P. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proc. Assoc. Am. Phys. 1996, 108:374-381.
14. Glasner A., Avraham R., Rosenne E., Benish M., Zmora O., Shemer S., Meiboom H., Ben-Eliyahu S. Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor. J. Immunol. 2010, 184:2449-2457.
15. Goodwin J.S., Webb D.R. Regulation of the immune response by prostaglandins. Clin. Immunol. Immunopathol. 1980, 15:106-122.
16. Gray I., Young J.G. Biochemical response to trauma. III. Epinephrine and norepinephrine levels in plasma of rats subjected to tumbling trauma. Am. J. Physiol. 1956, 186:67-70.
17. Greenfeld K., Avraham R., Benish M., Goldfarb Y., Rosenne E., Shapira Y., Rudich T., Ben-Eliyahu S. Immune suppression while awaiting surgery and following it: dissociations between plasma cytokine levels, their induced production, and NK cell cytotoxicity. Brain Behav. Immun. 2007, 21:503-513.
18. Gwosdow A.R., O'Connell N.A., Spencer J.A., Kumar M.S., Agarwal R.K., Bode H.H., Abou-Samra A.B. Interleukin-1-induced corticosterone release occurs by an adrenergic mechanism from rat adrenal gland. Am. J. Physiol. 1992, 263:E461-E466.
19. Haim S., Shakhar G., Rossene E., Taylor A.N., Ben-Eliyahu S. Serum levels of sex hormones and corticosterone throughout 4- and 5-day estrous cycles in Fischer 344 rats and their simulation in ovariectomized females. J. Endocrinol. Invest. 2003, 26:1013-1022.
20. Hasko G., Szabo C., Nemeth Z.H., Salzman A.L., Vizi E.S. Stimulation of beta-adrenoceptors inhibits endotoxin-induced IL-12 production in normal and IL-10 deficient mice. J. Neuroimmunol. 1998, 88:57-61.
21. Heikinheimo O., Pesonen U., Huupponen R., Koulu M., Lahteenmaki P. Hepatic metabolism and distribution of mifepristone and its metabolites in rats. Hum. Reprod. 1994, 9(Suppl. 1):40-46.
22. Iwasaki K., Noguchi K., Endo H., Kondo H., Ishikawa I. Prostaglandin E2 downregulates interleukin-12 production through EP4 receptors in human monocytes stimulated with lipopolysaccharide from Actinobacillus actinomycetemcomitans and interferon-gamma. Oral Microbiol. Immunol. 2003, 18:150-155.
23. Jones R.A. Etodolac: an overview of a selective COX-2 inhibitor. Inflammopharmacology 1999, 7:269-275.
24. Kanegane C., Sgadari C., Kanegane H., Teruya-Feldstein J., Yao L., Gupta G., Farber J.M., Liao F., Liu L., Tosato G. Contribution of the CXC chemokines IP-10 and Mig to the antitumor effects of IL-12. J. Leukoc. Biol. 1998, 64:384-392.
25. Kaye B., Cussans N.J., Faulkner J.K., Stopher D.A., Reid J.L. The metabolism and kinetics of doxazosin in man, mouse, rat and dog. Br. J. Clin. Pharmacol. 1986, 21(Suppl. 1):19S-25S.
26. Liedtke C.M. Interaction of epinephrine with isolated rabbit tracheal epithelial cells. Am. J. Physiol. 1986, 251:C209-C215.
27. Meron G., Tishler Y., Shaashua L., Rosenne E., Levi B., Melamed R., Gotlieb N., Matzner P., Sorski L., Ben-Eliyahu S. PGE(2) suppresses NK activity in vivo directly and through adrenal hormones: effects that cannot be reflected by ex vivo assessment of NK cytotoxicity. Brain Behav. Immun. 2013, 28:128-138.
28. Messmer D., Hatsukari I., Hitosugi N., Schmidt-Wolf I.G., Singhal P.C. Morphine reciprocally regulates IL-10 and IL-12 production by monocyte-derived human dendritic cells and enhances T cell activation. Mol. Med. 2006, 12:284-290.
29. Metzger D.W., McNutt R.M., Collins J.T., Buchanan J.M., Van Cleave V.H., Dunnick W.A. Interleukin-12 acts as an adjuvant for humoral immunity through interferon-gamma-dependent and -independent mechanisms. Eur. J. Immunol. 1997, 27:1958-1965.
30. Mohn C.E., Fernandez-Solari J., De Laurentiis A., Prestifilippo J.P., de la Cal C., Funk R., Bornstein S.R., McCann S.M., Rettori V. The rapid release of corticosterone from the adrenal induced by ACTH is mediated by nitric oxide acting by prostaglandin E2. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:6213-6218.
31. Murphy T.L., Cleveland M.G., Kulesza P., Magram J., Murphy K.M. Regulation of interleukin 12 p40 expression through an NF-kappa B half-site. Mol. Cell. Biol. 1995, 15:5258-5267.
32. Neeman E., Ben-Eliyahu S. Surgery and stress promote cancer metastasis: new outlooks on perioperative mediating mechanisms and immune involvement. Brain Behav. Immun. 2013, 30(Suppl.):S32-S40.
33. Neeman E., Shaashua L., Benish M., Page G.G., Zmora O., Ben-Eliyahu S. Stress and skin leukocyte trafficking as a dual-stage process. Brain Behav. Immun. 2012, 26:267-276.
34. Neeman E., Zmora O., Ben-Eliyahu S. A new approach to reducing postsurgical cancer recurrence: perioperative targeting of catecholamines and prostaglandins. Clin. Cancer Res. 2012, 18:4895-4902.
35. O'Connell N.A., Kumar A., Chatzipanteli K., Mohan A., Agarwal R.K., Head C., Bornstein S.R., Abou-Samra A.B., Gwosdow A.R. Interleukin-1 regulates corticosterone secretion from the rat adrenal gland through a catecholamine-dependent and prostaglandin E2-independent mechanism. Endocrinology 1994, 135:460-467.
36. Page G.G., Ben-Eliyahu S., Liebeskind J.C. The role of LGL/NK cells in surgery-induced promotion of metastasis and its attenuation by morphine. Brain Behav. Immun. 1994, 8:241-250.
37. h1 development by selective inhibition of interleukin 12. J. Clin. Invest. 1997, 100:1513-1519.
38. Sacerdote P. Effects of in vitro and in vivo opioids on the production of IL-12 and IL-10 by murine macrophages. Ann. N. Y. Acad. Sci. 2003, 992:129-140.
39. Schafer-Korting M., Bach N., Knauf H., Mutschler E. Pharmacokinetics of nadolol in healthy subjects. Eur. J. Clin. Pharmacol. 1984, 26:125-127.
40. Seltzer J.L., Goldberg M.E., Larijani G.E., Ritter D.E., Starsnic M.A., Stahl G.L., Lefer A.M. Prostacyclin mediation of vasodilation following mesenteric traction. Anesthesiology 1988, 68:514-518.
41. Shaashua L., Sominsky L., Levi B., Sorski L., Reznick M., Page G.G., Ben-Eliyahu S. In vivo suppression of plasma IL-12 levels by acute and chronic stress paradigms: potential mediating mechanisms and sex differences. Brain Behav. Immun. 2012, 26:996-1005.
42. Shakhar G., Ben-Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients?. Ann. Surg. Oncol. 2003, 10:972-992.
43. Shavit Y., Martin F.C., Yirmiya R., Ben-Eliyahu S., Terman G.W., Weiner H., Gale R.P., Liebeskind J.C. Effects of a single administration of morphine or footshock stress on natural killer cell cytotoxicity. Brain Behav. Immun. 1987, 1:318-328.
44. Shi J.M., Lai S.G., Xu C.J., Duan G.L., Li D. Pharmacokinetic difference between S-(+)- and R-(-)-etodolac in rats. Acta Pharmacol. Sin. 2004, 25(8):996-999.
45. Sloan E.K., Priceman S.J., Cox B.F., Yu S., Pimentel M.A., Tangkanangnukul V., Arevalo J.M., Morizono K., Karanikolas B.D., Wu L., Sood A.K., Cole S.W. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res. 2010, 70:7042-7052.
46. Stern A.S., Magram J., Presky D.H. Interleukin-12 an integral cytokine in the immune response. Life Sci. 1996, 58:639-654.
47. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 2003, 3:133-146.
48. van der Pouw Kraan T.C., Boeije L.C., Smeenk R.J., Wijdenes J., Aarden L.A. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 1995, 181:775-779.
49. Weiner G.J. The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides. J. Leukoc. Biol. 2000, 68:455-463.
50. Yakar I., Melamed R., Shakhar G., Shakhar K., Rosenne E., Abudarham N., Page G.G., Ben-Eliyahu S. Prostaglandin e(2) suppresses NK activity in vivo and promotes postoperative tumor metastasis in rats. Ann. Surg. Oncol. 2003, 10:469-479.
51. Yoburn B.C., Cohen A.H., Inturrisi C.E. Pharmacokinetics and pharmacodynamics of subcutaneous naltrexone pellets in the rat. J. Pharmacol. Exp. Ther. 1986, 237:126-130.
52. + T cells through phosphatidylinositol 3-kinase/Akt signaling pathway. J. Immunol. 2002, 169:3637-3643.
53. Zagron G., Weinstock M. Maternal adrenal hormone secretion mediates behavioural alterations induced by prenatal stress in male and female rats. Behav. Brain Res. 2006, 175:323-328.